Year: 2021
Type: article
Abstract: time from initiation of 1L to 2L therapy was 25 months (range 1-131).
Source: Hematological Oncology
DOI: 10.1002/hon.60_2880
Authors: R. Karmali, A. Donovan, N. Wagner‐Johntson, M. Messmer, A. Mehta, J. K. Anderson, N. Reddy, A. E. Kovach, D. J. Landsburg, M. Glenn, D. J. Inwards, K. Ristow, F. Lansigan, J. B. Kaplan, P. B. Caimi, S. Rajguru, A. Evens, A. Klein, E. Umyarova, J. E. Amengual, J. K. Lue, C. Diefenbach, N. Epperla, S. K. Barta, F. J Hernandez‐Ilizaliturri, E. Handorf, D. Villa, A. S. Gerrie, S. Li, J. Mederios, M. Wang, J. Cohen, O. Calzada, M. Churnetski, B. Hill, Y. Sawalha, J. N. Gerson, S. Kothari, J. M. Vose, M. Bast, T. S. Fenske, S. Narayana Rao Gari, K. J. Maddocks, D. Bond, V. Bachanova, B. Kolla, J. Chavez, B. Shah
Institutions: Northwestern University, Dartmouth–Hitchcock Medical Center, Johns Hopkins University, University of Alabama, University of Alabama at Birmingham, Vanderbilt-Ingram Cancer Center, University of Pennsylvania, Huntsman Cancer Institute, Mayo Clinic, Case Western Reserve University, University of Wisconsin System, University of Wisconsin–Madison, Rutgers, The State University of New Jersey, Tufts Medical Center, University of Vermont, New York University, The Ohio State University, Roswell Park Comprehensive Cancer Center, Fox Chase Cancer Center, BC Cancer Agency, The University of Texas MD Anderson Cancer Center, Emory Healthcare, Emory University, University of Nebraska Medical Center, Medical College of Wisconsin, Medical College of Wisconsin Cancer Center, University of Minnesota, Moffitt Cancer Center
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W3176870207